








Factors affecting drug adherence in patients with schizophrenia
－Basic study focusing on patients ready for hospital discharge－
Mitsunobu MATSUDA1), Ayumi KONO1), and Ryo SAKITANI2)
SUMMARY
　　This study aimed to explore factors affecting drug adherence before hospital discharge in patients 
with schizophrenia, and determine the implications for nursing practice. 
　　The subjects were 22 patients with schizophrenia (male: 9, female: 13) who had been hospitalized in 
acute psychiatric units (mean age: 44.6±13.0 years, mean disease duration: 12.7±13.5 years, mean 
number of hospitalizations: 2.8±3.1 times) and 15 participants in a psychoeducational program. The 
subjects’ demographic data, therapeutic situation, CP equivalents, assessment of overall function, drug 
adherence, and knowledge of medication and disease were measured before conducting the 
psychoeducational program, and CP equivalents, assessment of overall function, drug adherence, and 
knowledge of medication and disease were re-measured after the final session of the program. Data were 
forcibly entered into a multiple regression analysis. As the results, age, disease duration, occupation, 
participation in the psychoeducational program, and drug adherence at the initial measurement (MPS, 
DAI-10) were identified as factors affecting drug adherence, which significantly explained 78-86% of the 
variance. 
　　These results suggest the need for drug adherence support considering each patient’s individuality, 
and the possibility of employing a psychoeducational program to promote nursing support for 
improving a patient’s drug adherence.
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⑶　疾病薬物知識度調査（Knowledge of Illness 






























































































































































a 12.7 ±13.5 0.0 －42.0
過去の入院回数




CP換算値（開催前） 744.7 ±437.1 200.0 －2025.0
CP換算値（開催後） 849.4 ±393.0 200.0 －1550.0
精神状態
GAF(開催前） 59.6 ±13.6 40.0 －90.0
GAF(開催後） 62.7 ±13.9 50.0 －90.0
病気と服薬の知識
KIDI(開催前） 11.9 ±4.0 5.0 －18.0
KIDI(開催後） 13.2 ±3.5 8.0 －19.0
服薬アドヒアランス
MPS（開催前） 22.2 ±8.0 7.0 －34.0
MPS（開催後） 24.4 ±8.2 6.0 －39.0
DAI-10（開催前） 7.1 ±2.4 2.0 －10.0














































MPS総得点（開催前） 0.62 0.50 **
MPS総得点（開催後）                             - 0.85 **











年齢 0.34 * 0.32 *
性別 -0.17 -0.32 ***
職業の有無 0.29 * 0.28 *
同居者の有無 0.49 ** 0.21
罹患期間 0.52 *** 0.29 *
心理教育参加の有無 -0.39 ** -0.28 *
MPS総得点（開催前） -0.46 * -0.73 ***
DAI-10総得点（開催前） 0.93 *** 1.23 ***
R2 乗 0.87 0.91
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